Fred Alger Management, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Fred Alger Management, LLC

$19.8 Billion
Q3 2024

A detailed history of Fred Alger Management, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Fred Alger Management, LLC holds 93,446 shares of MDGL stock, worth $32.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

93,446

Previous 102,455 8.79%

Holding current value

$32.3 Million

Previous $28.7 Million 30.91%

% of portfolio

0.1%

Previous 0.14%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$212.22 - $292.96 $1.91 Million - $2.64 Million	-9,009 Reduced 8.79%	93,446 $19.8 Million
Q2 2024 Aug 14, 2024	BUY	$193.33 - $291.99 $7.32 Million - $11.1 Million	37,879 Added 58.66%	102,455 $28.7 Million
Q1 2024 May 15, 2024	BUY	$171.37 - $283.23 $7.97 Million - $13.2 Million	46,479 Added 256.83%	64,576 $17.2 Million
Q4 2023 Feb 14, 2024	SELL	$120.4 - $237.13 $212,746 - $419,008	-1,767 Reduced 8.9%	18,097 $4.19 Million
Q3 2023 Nov 14, 2023	BUY	$146.04 - $225.78 $66,594 - $102,955	456 Added 2.35%	19,864 $2.9 Million
Q2 2023 Aug 14, 2023	SELL	$203.88 - $312.0 $297,257 - $454,896	-1,458 Reduced 6.99%	19,408 $4.48 Million
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $1.1 Million - $1.46 Million	4,746 Added 29.44%	20,866 $5.05 Million
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $941,246 - $4.78 Million	16,120 New	16,120 $4.68 Million
Q3 2019 Nov 14, 2019	SELL	$84.4 - $106.53 $928,400 - $1.17 Million	-11,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$91.13 - $142.5 $668,256 - $1.04 Million	-7,333 Reduced 40.0%	11,000 $1.15 Million
Q1 2019 May 14, 2019	SELL	$103.48 - $143.84 $20,178 - $28,048	-195 Reduced 1.05%	18,333 $2.3 Million
Q4 2018 Feb 14, 2019	BUY	$94.77 - $215.54 $547,960 - $1.25 Million	5,782 Added 45.36%	18,528 $2.09 Million
Q3 2018 Nov 14, 2018	SELL	$207.3 - $300.31 $473,058 - $685,307	-2,282 Reduced 15.18%	12,746 $2.73 Million
Q2 2018 Jul 19, 2018	BUY	$101.55 - $313.9 $612,143 - $1.89 Million	6,028 Added 66.98%	15,028 $4.2 Million
Q1 2018 May 10, 2018	BUY	$93.35 - $149.04 $280,050 - $447,120	3,000 Added 50.0%	9,000 $1.05 Million
Q4 2017 Feb 14, 2018	BUY	$39.35 - $97.37 $236,100 - $584,220	6,000	6,000 $551,000

Others Institutions Holding MDGL

# of Institutions

298

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.9B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account

Fred Alger Management, LLC Madrigal Pharmaceuticals, Inc. Transaction History